Washington Trust’s Corbus Pharmaceuticals CRBP Stock Holding History

Washington Trust’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-83	Closed	-$3K	–	959
2021 Q3	$3K	Hold	83	–	–	﹤0.01%	899
2021 Q2	$5K	Hold	83	–	–	﹤0.01%	860
2021 Q1	$5K	Hold	83	–	–	﹤0.01%	820
2020 Q4	$3K	Hold	83	–	–	﹤0.01%	830
2020 Q3	$5K	Hold	83	–	–	﹤0.01%	789
2020 Q2	$20K	Sell	83 -67	-45%	-$13.5K	﹤0.01%	554
2020 Q1	$24K	Buy	+150	New	+$25.4K	﹤0.01%	515
2018 Q3	–	Sell	-150	Closed	-$23K	–	361
2018 Q2	$23K	Buy	+150	New	+$27.3K	﹤0.01%	546

Other funds holding CRBP

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Washington Trust's CRBP Position: Q4 2021 in Review

Washington Trust sold out of Corbus Pharmaceuticals (CRBP) in Q4 2021, closing a stake of 83 shares — an estimated $3K sold.

Washington Trust first reported a position in CRBP in Q2 2018 and held it in 8 quarters. The position peaked at $24K in Q1 2020. 82 funds tracked by Wall St. Rank hold CRBP as of Q4 2021.

Washington Trust reported no remaining Corbus Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Washington Trust sold 83 Corbus Pharmaceuticals shares in Q4 2021, an estimated $3K.
Washington Trust first reported a position in Corbus Pharmaceuticals in Q2 2018 and held it in 8 quarters.
Washington Trust's Corbus Pharmaceuticals position peaked at $24K in Q1 2020.
82 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2021.

Based on Washington Trust's 13F filing for Q4 2021, filed 9 Feb 2022.